Clinical Trials
3 trialsNCT04582487 2024-02-07
Advancing Chemical and Genomic Strategies for Relapsed/Refractory T-ALL and ETP-ALL
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase NA Unknown
NCT04785833 2021-03-08
CD7 CAR-T in the Treatment of CD7 Positive Refractory Relapsed Acute Leukemia
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase NA Unknown
NCT04620655 2020-11-09
RD13-01 for Patients With r/r CD7+ T-ALL/T-LBL
Hebei Yanda Ludaopei Hospital
Phase NA Unknown